Finnpipette BioControl Single Channel, 200-1000ul

Products	Finnpipette BioControl Single Channel, 200-1000ul
Company	ThermoFisher Scientific
Item	Finnpipette BioControl Single Channel, 200-1000ul
Features
Description	The Finnpipette BioControl is a major step forward in electronic pipetting technology. A complete liquid handling system - with one universal handle and twelve interchangeable tip cone modules. All five single channel and seven multichannel tip cone modules fit one handle. The lightweight handle is ergonomically designed to improve operator comfort and efficiency.
Info	ThermoFisher Scientific Web site: http://www.thermo.com Web site: http://www.thermofisher.com/global/en/home.asp

TAG: Finnpipette BioControl Single Channel

Short examining bridge for insertion of instruments

Designed for accurate articulation of flexible devices.

...PVC, Length 30cm (12") Spiral Tip, 1/56" female th...struments are constructed of a strong but flexible... which allow interchangeability with other brands....hey are also economically priced to give you signi...

It is available in a 5cc-balloon version with round tip and two opposing eyes, and a 30cc-balloon version with two staggered eyes. BARDEX Silicone-Elastomer Foley Catheters are also available in kits

Medicine Products:

S-Series Cystourethroscope Short Bridge, examining P-Series Cystourethroscope Albarran Bridge, single-horn Filiform Spiral Tip BARDEX Silicone-Elastomer 2-Way Foley Catheters

(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...

(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...

(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...

(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...

[0] Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use [0] Medicare Advantage Plans Struggle to Comply With New Federal Law [0] Longs Drug Stores Corporation Reports Second Quarter Results [0] WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History

...t consuming the right type of fat may actually kee...ted to consume lesser quantities// of unsaturated ...hy children in the age group of four was undertake...These children belong to families with good socio-...

...nnounced that it is teaming up with Weight Watcher...ses to help// fight obesity in more than 75000 peo... beneficiaries in West Virginia are eligible to ta...tchers, famous for its regular meetings and system...

...thal Prion diseases has been brought to light by r...shed in an online edition of PLoS Biology. Resea...rotein Hsp 104 is responsible for the spread and m...rotein breaks up groups of such infectious protein...

...r Girija Prasad Koirala's sister-in-law and Nepal'...attling jaundice, kidney problems and other infect...s been admitted to Shahid Gangalal National Heart ...togenarian premier himself had stayed for treatmen...

Other Medicine News:Health News:Nepal's Most Influential Woman 'Critically' Ill 2

Less of Omega- 3 in Obese Children West Virginia Organizes a Program to Fight Obesity Role of Hsp 104 in the Spread of Prion Diseases Nepal's Most Influential Woman 'Critically' Ill

(Date:8/19/2008)...., Aug. 19 /- Addrenex Pharmaceutical...ategic hires this month to,further its goal of ide...s,as possible over the next 18 months., The fast-...rrors the,company,s recent successes in developing...hyperactivity disorder and CloniBID for hypertensi...

(Date:8/19/2008)...Conn., Aug. 19 /- VION,PHAR...day that it had,entered into an agreement with the...ogy Oncology (the "HOVON") to conduct a clinical t...ith standard remission-induction,therapy in patien...ogenous,leukemia (AML) and high-risk myelodysplasi...

(Date:8/18/2008).... 18 /PRNewswire-USNewswire/ -- Boston University ...the Center for Human Genetics, Inc.,("CHG") and Di...University,announced that CHG will no longer offe...Athena Diagnostics, Inc., These patented tests in...ated to A1555G or Connexin 26 mutations, developme...

(Date:8/18/2008)...der with Strong Clinical Research Relationships an...ations to Lead Commercialization, SANTA CLARA, Ca... Inc.,(OTC Bulletin Board: NWCI) a cardiac diagno...ncent W. Renz has joined NewCardio as its presiden...zation effort, to include,business development, cl...

Breaking Medicine Technology:Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 2 Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 3 Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2 Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3 Vincent W. Renz Joins NewCardio as President 2 Vincent W. Renz Joins NewCardio as President 3 Vincent W. Renz Joins NewCardio as President 4 Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston MA 36 1 Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston MA 36 2 Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston MA 36 3 Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction 33 1 Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction 33 2 Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction 33 3 Dynavax Issued Landmark Patent Covering Second Generation TLR9 Agonists 30 1 Dynavax Issued Landmark Patent Covering Second Generation TLR9 Agonists 30 2 China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results 27 1 China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results 27 2 China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results 27 3

[0] Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation [0] Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy [0] Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services [0] Vincent W. Renz Joins NewCardio as President

...resented at ECCMID/ICC, MUNICH, Germany, April 03,...announced results from two studies showing the,imp...wth in vitro,when tested with a common wetting age...e activity of oritavancin against S.,pneumoniae in...lipoglycopeptide antibiotic, is Targanta,s lead pr...

... Suppresses Amyloid Plaque,Formation , ANNAPOLIS, ...biodefense company specializing in the development...against chemical and,biological terrorism, announc...lcholinesterase (rBChE) research program were,rece... on,Alzheimer,s and Parkinson,s Diseases in Salzbu...

Other Medicine Technology:Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 2 Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 3 Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 4 Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 5 Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 6 Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 2 Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 3 Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 4 Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 5 Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 6

Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research